CIK 0001731348 · Large accelerated filer
Tilray Brands, Inc.
Sign in to watch- Ticker
- TLRY
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- May 31
- Entity type
- operating
- EIN
- 824310622
- Phone
- 519.322.8800
- Business address
- 445 PARK AVENUE, NEW YORK, NY, 10022
- Former names
- Tilray, Inc.
- 4 Option exercise Chief Financial Officer acquired 93,928 shares (option exercise)
- 4 Open-market buy Global General Counsel bought 6,000 shares at $0.58 ($3,496)
- 4 Option exercise Chief Strategy Officer acquired 93,928 shares (option exercise)
- 4 Option exercise Chief Strategy Officer acquired 261,194 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Option exercise Director acquired 124,378 shares (option exercise)
- 4 Option exercise Director acquired 124,378 shares (option exercise)
- 4 Option exercise Director acquired 124,378 shares (option exercise)
- 4 Option exercise Director acquired 124,378 shares (option exercise)
- 4 Option exercise Director acquired 124,378 shares (option exercise)
- 4 Option exercise Global General Counsel acquired 243,781 shares (option exercise)
- 4 Option exercise Chief Financial Officer acquired 166,558 shares (option exercise)
- 4 Option exercise President and CEO acquired 1,176,467 shares (option exercise)
- 4 Open-market buy President and CEO bought 165,000 shares at $0.61 ($100,106)
- 4 Open-market buy Chief Financial Officer bought 33,500 shares at $0.60 ($19,939)
- 4 Option exercise President and CEO acquired 1,178,109 shares (option exercise)
- 4 Option exercise Chief Financial Officer acquired 174,477 shares (option exercise)
- 4 Option exercise Chief Strategy Officer acquired 249,353 shares (option exercise)
- 4 Option exercise Global General Counsel acquired 231,218 shares (option exercise)
- 4 Derivatives Options or other derivatives
Page 2 of 17 · 334 filings